October 15, 2024 | Media, News, Press Release, Progressive
Pharmac’s decision-making process for funding drugs in Aotearoa New Zealand is in need of a major overhaul – according to a new independent report. The Milne Report, commissioned by Multiple Sclerosis New Zealand (MSNZ), says its time Pharmac based its […]
Multiple Sclerosis (MS) is a long-term, progressive neurological disease. The cornerstone of any long-term condition is optimal and proactive management. Ongoing monitoring for treatment efficacy and signs of progression is important to minimise long-term disability in MS. In an ideal […]
September 5, 2024 | Media, News
Progressive neurological illness characterised by episodic deterioration has been observed and documented since the late 1300s. In the mid-19th century, multiple sclerosis (MS) was described as an identifiable entity based on its pathology (Murray, 2009). Since then, the process of […]
May 15, 2024 | Advocacy, Funding, Life with MS, Media, News, Press Release, Treatments
A celebrated Pharmac decision late last year to fund a vital drug for many Multiple Sclerosis patients has fallen flat – with dozens being turned away for treatment due to severely stretched resources across a number of services. Multiple Sclerosis […]
March 25, 2024 | Event, Media, Press Release
FOR IMMEDIATE RELEASE 25th March 2024 Bangers to Bluff 2024: A Journey of Endurance and Support for MS New Zealand Bangers to Bluff®, the Rotary Club of Half Moon Bay’s annual automotive charity event, is gearing up for its highly […]